Dana Walker

Dana Walker

UNVERIFIED PROFILE

Are you Dana Walker?   Register this Author

Register author
Dana Walker

Dana Walker

Publications by authors named "Dana Walker"

Are you Dana Walker?   Register this Author

40Publications

1175Reads

26Profile Views

Method development and laboratory intercomparison of an RP-HPLC-UV method for energetic chemicals in marine tissues.

Talanta 2019 Jun 6;198:284-294. Epub 2019 Feb 6.

US Environmental Protection Agency, Region 10 Laboratory, 7411 Beach Dr. E., Port Orchard, WA 98366, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.talanta.2019.02.005DOI Listing
June 2019

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.

J Clin Oncol 2018 02 3;36(4):383-390. Epub 2017 Jul 3.

James Larkin, Royal Marsden NHS Foundation Trust, London; Paul Lorigan, The Christie National Health Service Foundation Trust, Manchester, United Kingdom; David Minor, California Pacific Medical Center Research Institute; Adil Daud, University of California San Francisco, San Francisco; Bartosz Chmielowski, University of California, Santa Monica, CA; Sandra D'Angelo, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; Jeffrey Weber, Perlmutter Cancer Center at New York University-Langone Medical Center, New York; Nikhil Khushalani, Roswell Park Cancer Institute, Buffalo, NY; Gerald Linette, Washington University, St. Louis, MO; Christopher D. Lao, University of Michigan, Ann Arbor, MI; Kenneth Grossmann, Huntsman Cancer Institute, Salt Lake City, UT; Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT; Jeffrey Sosman, Northwestern University, Chicago, IL; Dana Walker, George Kong, and Christine Horak, Bristol-Myers Squibb, Princeton, NJ; Bart Neyns, University Hospital, Vrije Universiteit Brussel, Brussels, Belgium; Michael Smylie, Cross Cancer Institute, Edmonton, Alberta; Wilson H. Miller Jr, Jewish General Hospital and Segal Cancer Centre, McGill University, Montreal, Quebc, Canada; Ralf Gutzmer, Medizinische Hochschule Hannover, Hannover; Jessica C. Hassel, Nationale Centrum für Tumorerkrankungen Heidelberg, Heidelberg; Dirk Schadendorf, University Hospital Essen, Essen, Germany; and Christoph Hoeller, Medical University of Vienna, Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.8023DOI Listing
February 2018

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials.

J Clin Oncol 2017 Dec 25;35(34):3807-3814. Epub 2017 Aug 25.

Dirk Schadendorf, University Hospital Essen and the German Cancer Consortium, Essen, Germany; Jedd D. Wolchok and Michael A. Postow, Memorial Sloan Kettering Cancer Center; Michael A. Postow, Weill Cornell Medical College, New York, NY; F. Stephen Hodi, Dana-Farber Cancer Institute; David McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Vanna Chiarion-Sileni, Istituto Oncologico Veneto, Veneto, Italy; Rene Gonzalez, University of Colorado Denver, Aurora, CO; Piotr Rutkowski, Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jean-Jacques Grob, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille Timone, Marseille; Caroline Robert, Gustave Roussy and Université Paris-Sud, Paris, France; C. Lance Cowey, Texas Oncology-Baylor Cancer Center, Dallas, TX; Christopher D. Lao, University of Michigan, Ann Arbor, MI; Jason Chesney, University of Louisville, Louisville, KY; Kenneth Grossmann, Huntsman Cancer Institute, Salt Lake City, UT; Dana Walker and Rafia Bhore, Bristol-Myers Squibb, Princeton, NJ; and James Larkin, Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.2289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791828PMC
December 2017

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.

J Clin Oncol 2017 Dec 15;35(34):3815-3822. Epub 2017 Sep 15.

Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT; Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan; Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Pascal Wolter, University Hospitals Leuven, Leuven, Belgium; Celeste Lebbé, Université Paris Diderot, Paris; Luc Thomas, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France; John M. Kirkwood, Hillman Cancer Center, Pittsburgh, PA; Jacob Schachter, Sheba Medical Center, Ramat Gan, Israel; Gregory A. Daniels, University of California San Diego, Moores Cancer Center, La Jolla, CA; Jessica Hassel, University Hospital, Heidelberg, Germany; Jonathan Cebon, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria; Winald Gerritsen, University of Queensland, St Lucia; Victoria Atkinson, Gallipoli Medical Research Foundation, Greenslopes; Victoria Atkinson, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Winald Gerritsen, Radboud University Medical Center, Nijmegen, the Netherlands; John McCaffrey, Irish Clinical Oncology Research Group, Dublin; Derek Power, Irish Clinical Oncology Research Group, Cork, Ireland; Dana Walker, Rafia Bhore, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; and Jedd D. Wolchok, Parker Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.1167DOI Listing
December 2017

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group.

J Clin Oncol 2017 Nov 2;35(33):3753-3759. Epub 2017 Oct 2.

Stuart M. Lichtman, Memorial Sloan Kettering Cancer Center, Commack, NY; R. Donald Harvey, Emory University School of Medicine, Atlanta, GA; Marie-Anne Damiette Smit and Atiqur Rahman, US Food and Drug Administration, Silver Spring, MD; Michael A. Thompson, Aurora Health Care, Milwaukee, WI; Nancy Roach, Fight Colorectal Cancer, Springfield, MO; Caroline Schenkel and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Patricia Cortazar, Genentech, South San Francisco; Louis Fehrenbacher, Kaiser Permanente Northern California, Vallejo, CA; and Dana Walker, Bristol-Myers Squibb, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.4102DOI Listing
November 2017

Heavy-Atom Tunneling Calculations in Thirteen Organic Reactions: Tunneling Contributions are Substantial, and Bell's Formula Closely Approximates Multidimensional Tunneling at ≥250 K.

Angew Chem Int Ed Engl 2017 10 18;56(42):13099-13102. Epub 2017 Sep 18.

Baruch College of the City University of New York, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.201708489DOI Listing
October 2017

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

N Engl J Med 2017 10 11;377(14):1345-1356. Epub 2017 Sep 11.

From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; University of Colorado, Denver (R.G.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); Aix-Marseille University, Hôpital de la Timone, Marseille (J.-J.G.), and Assistance Publique-Hôpitaux de Paris, Dermatology and Centres d'Investigation Clinique, INSERM Unité 976, Hôpital Saint-Louis, Université Paris Diderot, Paris (C.L.) - both in France; Texas Oncology-Baylor Cancer Center, Dallas (C.L.C.); University of Michigan, Ann Arbor (C.D.L.); the College of Medicine, Swansea University, Swansea (J.W.), and Royal Marsden NHS Foundation Trust, London (J.L.) - both in the United Kingdom; the Department of Dermatology, University of Essen, Essen, and the German Cancer Consortium, Heidelberg - both in Germany (D.S.); Cross Cancer Institute, Edmonton, AB (M.S.), and Princess Margaret Cancer Centre, Toronto (D.H.) - both in Canada; Universitäts Spital, Zurich, Switzerland (R.D.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), Crown Princess Mary Cancer Centre, Melanoma Institute Australia, University of Sydney (M.S.C.), and Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals (G.V.L.), Sydney, and Peter MacCallum Cancer Centre (G.M.) and the Olivia Newton-John Cancer Research Institute, University of Melbourne (J.C.), Melbourne, VIC - all in Australia; Netherlands Cancer Institute, Amsterdam (J.H.); University Hospitals Leuven, KU Leuven, Leuven, Belgium (O.B.); General University Hospital Gregorio Marañón, Madrid (I.M.-R.); Northwestern University, Chicago (J.S.); Bristol-Myers Squibb, Princeton, NJ (D.W., L.R., R.B.); and the Dana-Farber Cancer Institute, Boston (F.S.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706778PMC
October 2017

Session Overview: Bone as an Endocrine Organ.

Toxicol Pathol 2017 10 3;45(7):884-886. Epub 2017 Oct 3.

2 Kirkland, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0192623317734812DOI Listing
October 2017

Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development.

Toxicol Pathol 2016 Feb 2;44(2):137-46. Epub 2016 Feb 2.

Novartis Institute of Biomedical Research, Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0192623315620051DOI Listing
February 2016

Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients.

Pediatr Blood Cancer 2015 Apr 26;62(4):704-9. Epub 2014 Mar 26.

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177031PMC
April 2015

Comparison of cardiac troponin I and T, including the evaluation of an ultrasensitive assay, as indicators of doxorubicin-induced cardiotoxicity.

Toxicol Pathol 2013 26;41(8):1146-58. Epub 2013 Mar 26.

1Pfizer Global Research Development, Groton, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0192623313482056DOI Listing
August 2014

Current practices in preclinical drug development: gaps in hemostasis testing to assess risk of thromboembolic injury.

Toxicol Pathol 2013 18;41(3):445-53. Epub 2012 Sep 18.

Department of Pathology, Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0192623312460924
Publisher Site
http://dx.doi.org/10.1177/0192623312460924DOI Listing
February 2014

Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.

Pediatr Crit Care Med 2014 Feb;15(2):112-20

1Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA. 2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 3Department of Anesthesia and Critical Care Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA. 4Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 5Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA. 6Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, PA. 7Bristol-Myers Squibb, Hopewell, NJ. 8Division of Haematology/Oncology and Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada. 9Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 10Division of Pediatric Critical Care Medicine, Department of Pediatrics and Public Health Sciences, Penn State Hershey Milton S. Hershey Medical Center, Hershey, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PCC.0000000000000042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407366PMC
February 2014

Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data.

Med Care 2014 Jan;52(1):e1-6

*Division of Infectious Diseases †Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia ‡Department of Pediatrics §Center for Clinical Epidemiology and Biostatistics, the Perelman School of Medicine at the University of Pennsylvania ∥Division of Oncology, The Children's Hospital of Philadelphia ¶Department of Biostatistics and Epidemiology, the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MLR.0b013e31824deff9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381055PMC
January 2014

Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia.

Leuk Lymphoma 2013 Aug 26;54(8):1633-9. Epub 2012 Dec 26.

Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. fi

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.750722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906846PMC
August 2013

Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States.

J Pediatr 2013 Jun 24;162(6):1252-8, 1258.e1. Epub 2012 Dec 24.

Division of Oncology, Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, and Department of Pediatrics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2012.11.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909336PMC
June 2013

Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database.

Pediatr Blood Cancer 2013 Apr 4;60(4):616-20. Epub 2012 Sep 4.

Division of Oncology, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918414PMC
April 2013

Best practices for evaluation of bone marrow in nonclinical toxicity studies.

Vet Clin Pathol 2011 Jun;40(2):119-34

Pfizer Global Research and Development, Drug Safety Research and Development, 8274/1203 Eastern Point Rd., Groton, CT 06340, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1939-165X.2011.00323.xDOI Listing
June 2011

Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury.

Clin Chem 2008 Dec 9;54(12):1982-9. Epub 2008 Oct 9.

Department of Laboratory Medicine and Pathology, Hennepin County Medical Center and the University of Minnesota School of Medicine, Minneapolis, MN 55415, USA.

View Article

Download full-text PDF

Source
http://www.clinchem.org/cgi/doi/10.1373/clinchem.2007.097568
Publisher Site
http://dx.doi.org/10.1373/clinchem.2007.097568DOI Listing
December 2008

The Caenorhabditis elegans Rad17 homolog HPR-17 is required for telomere replication.

Genetics 2007 May 4;176(1):703-9. Epub 2007 Mar 4.

Department of Biology, University of North Carolina, Chapel Hill, North Carolina 27599-3280, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1534/genetics.106.070201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1893056PMC
May 2007

Serum chemical biomarkers of cardiac injury for nonclinical safety testing.

Authors:
Dana B Walker

Toxicol Pathol 2006 ;34(1):94-104

Wyeth Research Laboratories, Chazy, New York 12901, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01926230500519816DOI Listing
April 2006

Outcomes management of an ambulatory clinic system population: experience with patients with diabetes.

J Miss State Med Assoc 2004 Jun;45(6):163-8

North Mississippi Medical Center, Tupelo, USA.

View Article

Download full-text PDF

Source
June 2004

What is your diagnosis? Cerebrospinal fluid from a dog.

Vet Clin Pathol 1997 ;26(2):71

Department of Veterinary Anatomy and Public Health, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843.

View Article

Download full-text PDF

Source
January 1997

What is your diagnosis? Lung mass from a horse.

Vet Clin Pathol 1993 ;22(2):35

Department of Veterinary Pathology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078.

View Article

Download full-text PDF

Source
January 1993

Carcinoma in the urinary bladder of a cat: cytologic findings and a review of the literature.

Vet Clin Pathol 1993 ;22(4):103-108

Department of Veterinary Pathology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078.

View Article

Download full-text PDF

Source
January 1993